Cargando…
Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity
7-Ethyl-10-hydroxycamptothecin (SN38), an active metabolite of irinotecan (CPT-11), is a remarkably potent antitumor agent. The clinical application of SN38 has been extremely restricted by its insolubility in water. In this study, we successfully synthesized two macromolecular prodrugs of SN38 with...
Autores principales: | Liu, Yi, Piao, Hongyu, Gao, Ying, Xu, Caihong, Tian, Ye, Wang, Lihong, Liu, Jinwen, Tang, Bo, Zou, Meijuan, Cheng, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376263/ https://www.ncbi.nlm.nih.gov/pubmed/25848251 http://dx.doi.org/10.2147/IJN.S77957 |
Ejemplares similares
-
Synthesis and Antitumor Evaluation of Biotin-SN38-Valproic Acid Conjugates
por: Dai, Yi, et al.
Publicado: (2023) -
One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion
por: Sun, Xuanrong, et al.
Publicado: (2019) -
Investigation into the Efficacy of Val-SN-38, a Valine-Ester Prodrug of the Anti-Cancer Agent SN-38
por: Kwak, Eun-Young, et al.
Publicado: (2012) -
Does sacituzumab-govitecan act as a conventional antibody drug conjugate (ADC), a prodrug of SN-38 or both?
por: Santi, Daniel V., et al.
Publicado: (2021) -
Synthesis, characterization, and evaluation of mPEG–SN38 and mPEG–PLA–SN38 micelles for cancer therapy
por: Xie, Jing, et al.
Publicado: (2016)